Flu Vaccine Updates
The university is currently concentrating on administering the H1N1 vaccine to the campus community. As soon as the seasonal flu vaccine is again available, we will resume campuswide immunization clinics.
H1N1 Vaccine
Information regarding specific H1N1 vaccines will be circulated to the campus community as it becomes available via federal government programs. The H1N1 vaccination will be made available first to those who are considered by the Centers for Disease Control and Prevention to be at highest risk:
- Children younger than 5, but especially children younger than 2 years old
- Adults 65 years of age and older
- Pregnant women
People who have:
- Cancer
- Blood disorders (including sickle cell disease)
- Chronic lung disease, such as asthma or chronic obstructive pulmonary disease (COPD)
- Diabetes
- Heart disease
- Kidney disorders
- Liver disorders
- Neurological disorders (such as epilepsy, cerebral palsy, brain or spinal cord injuries, moderate to profound intellectual disability [mental retardation] or developmental delay)
- Neuromuscular disorders (such as muscular dystrophy and multiple sclerosis)
- Weakened immune systems (such as people with HIV or AIDS or who are on medications that weaken the immune system)
The next priority category includes all individuals between the ages of 18 and 24, and we expect to be vaccinating as many students as possible. Additional updates are forthcoming. Details about the university's planning for H1N1 and the seasonal flu are available online.